Core Viewpoint - Cisco Systems (CSCO) shares have increased by approximately 1.3% since the last earnings report, underperforming the S&P 500 index [1] Group 1: Earnings Report Insights - The recent earnings report indicates that estimates for Cisco have trended upward over the past month [2] - The stock has received a Zacks Rank of 3 (Hold), suggesting an expectation of in-line returns in the upcoming months [4] Group 2: VGM Scores - Cisco has an average Growth Score of C and a Momentum Score of C, while it received a D grade for Value, placing it in the bottom 40% for that investment strategy [3] - The overall aggregate VGM Score for Cisco is D, which is significant for investors not focused on a single strategy [3]

It has been about a month since the last earnings report for Nutrien (NTR) . Shares have added about 10.1% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Nutrien due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.How Have Estimates Been Moving Since Then?It turns out, ...

Core Viewpoint - Denali Therapeutics Inc. has seen a slight increase in share price of about 0.7% over the past month, underperforming the S&P 500, raising questions about the sustainability of this trend leading up to the next earnings release [1] Group 1: Earnings and Estimates - Estimates for Denali Therapeutics have trended upward over the past month, indicating positive revisions [2] - The stock has a Zacks Rank of 3 (Hold), suggesting an expectation of in-line returns in the coming months [4] Group 2: VGM Scores - Denali Therapeutics has a poor Growth Score of F, a Momentum Score of C, and a Value Score of F, resulting in an overall aggregate VGM Score of F, placing it in the lowest quintile for investment strategies [3] Group 3: Industry Comparison - Denali Therapeutics operates within the Zacks Medical - Biomedical and Genetics industry, where Moderna has experienced a gain of 13.3% over the past month [5] - Moderna reported revenues of $108 million for the last quarter, reflecting a year-over-year decline of 35.3%, with an EPS of -$2.52 compared to -$3.07 a year ago [5] - Moderna is projected to post a loss of $2.97 per share for the current quarter, with a year-over-year change of +10.8% and a Zacks Rank of 3 (Hold) [6]

A month has gone by since the last earnings report for Norwegian Cruise Line (NCLH) . Shares have added about 8.2% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Norwegian Cruise Line due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.How Have Estimates Been Moving Sin ...

Core Viewpoint - Ionis Pharmaceuticals has seen a 5.5% increase in share price over the past month, outperforming the S&P 500, raising questions about the sustainability of this trend leading up to the next earnings release [1] Group 1: Earnings Report and Estimates - The consensus estimate for Ionis Pharmaceuticals has shifted upward by 42.69% over the past month, indicating positive revisions in earnings expectations [2] - The recent earnings report highlights important drivers that may influence future performance [1] Group 2: VGM Scores - Ionis Pharmaceuticals has a poor Growth Score of F, while its Momentum Score is rated A, indicating strong short-term performance [3] - The stock has received an F grade on the value side, placing it in the lowest quintile for value investment strategy [3] - The overall aggregate VGM Score for the stock is F, which is significant for investors not focused on a single strategy [3] Group 3: Outlook - The upward trend in estimates suggests a promising outlook for Ionis Pharmaceuticals, with a Zacks Rank of 3 (Hold) indicating expectations for an in-line return in the coming months [4]

A month has gone by since the last earnings report for Valmont Industries (VMI) . Shares have added about 9.3% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Valmont due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.How Have Estimates Been Moving Since Then?It turns o ...

Core Viewpoint - Prologis shares have increased by approximately 7% over the past month, but this performance has lagged behind the S&P 500 index [1] Earnings Report Summary - The last earnings report for Prologis was about a month ago, and the stock's recent performance raises questions about whether the positive trend will continue or if a pullback is imminent [1] Estimates Movement - Estimates for Prologis have trended downward over the past month, indicating a negative shift in expectations [2] VGM Scores - Prologis has received a subpar Growth Score of D, a Momentum Score of D, and a Value Score of D, placing it in the bottom 40% for investment strategies [3] Outlook - The overall trend of downward estimate revisions suggests a negative outlook for Prologis, which currently holds a Zacks Rank of 3 (Hold), indicating an expectation of in-line returns in the coming months [4]

A month has gone by since the last earnings report for Liberty Oilfield Services (LBRT) . Shares have added about 1.1% in that time frame, underperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Liberty Oilfield Services due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.How Have Estimates Been ...

It has been about a month since the last earnings report for RH (RH) . Shares have added about 23.7% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is RH due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.How Have Estimates Been Moving Since Then?It turns out, estimates r ...